CVS Health Corporation Website

CVS Health Corporation

NYSE-CVS

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

255,765

267,908

290,912

321,629

356,623

361,855

Total Revenues % Chg.

31.9%

4.7%

8.6%

10.6%

10.9%

7%

Cost of Goods Sold, Total

211,248

219,660

239,991

267,965

303,345

309,851

Gross Profit

44,517

48,248

50,921

53,664

53,278

52,004

Selling General & Admin Expenses, Total

32,699

34,585

36,764

37,922

39,205

40,454

Other Operating Expenses, Total

32,699

34,585

36,764

37,922

39,205

40,454

Operating Income

11,818

13,663

14,157

15,742

14,073

11,550

Interest Expense, Total

-3,035

-2,907

-2,503

-2,287

-2,658

-2,831

Interest And Investment Income

1,011

798

1,199

838

1,153

1,393

Net Interest Expenses

-2,024

-2,109

-1,304

-1,449

-1,505

-1,438

Other Non Operating Income (Expenses)

—

-7

-12

-4

-4

-6

-1

EBT, Excl. Unusual Items

9,787

11,542

12,849

14,289

12,562

10,111

Restructuring Charges

—

—

—

-231

—

-1,358

-117

-553

-21

Merger & Related Restructuring Charges

—

-480

-332

-132

—

-487

-449

Impairment of Goodwill

—

—

—

—

—

-431

—

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

-2,533

-349

—

Asset Writedown

—

—

—

—

—

—

—

—

—

—

Legal Settlements

—

—

—

—

—

—

—

-5,803

—

—

Other Unusual Items

—

—

—

-79

-1,440

-391

—

—

—

EBT, Incl. Unusual Items

8,997

9,770

10,537

5,836

11,173

9,641

Income Tax Expense

2,366

2,569

2,548

1,509

2,805

2,437

Earnings From Continuing Operations

6,631

7,201

7,989

4,327

8,368

7,204

Earnings Of Discontinued Operations

—

—

-9

—

—

—

—

Minority Interest

—

3

-13

12

-16

-24

-14

Net Income

6,634

7,179

8,001

4,311

8,344

7,190

Preferred Dividend and Other Adjustments

5

—

—

—

—

—

Net Income to Common Incl Extra Items

6,629

7,179

8,001

4,311

8,344

7,190

Net Income to Common Excl. Extra Items

6,629

7,188

8,001

4,311

8,344

7,190

Total Shares Outstanding

1,302

1,310

1,322

1,300

1,288

1,256

Weighted Avg. Shares Outstanding

1,301

1,309

1,319

1,312

1,285

1,272.5

Weighted Avg. Shares Outstanding Dil

1,305

1,314

1,329

1,323

1,290

1,277

EPS

5.1

5.5

6.1

3.3

6.5

5.7

EPS Diluted

5.1

5.5

6

3.3

6.5

5.6

EBITDA

16,189

18,104

18,643

19,966

18,439

16,100

Effective Tax Rate

26.3%

26.3%

24.2%

25.9%

25.1%

25.3%